Propanc Biopharma Announces 1-for-10 Reverse Stock Split

Article summary

Propanc Biopharma, Inc. has approved a 1-for-10 reverse stock split of its common stock, effective as of the market open on October 26, 2026, to maintain compliance with Nasdaq listing standards.